LCG
PRVA icon

Lisanti Capital Growth’s Privia Health PRVA Stock Holding History

Lisanti Capital Growth’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-137,650
Closed -$4.69M – 154
2022
Q3 		$4.69M Buy
+137,650
New +$5.09M 0.63% 64

Other funds holding PRVA

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lisanti Capital Growth's PRVA Position: Q4 2022 in Review

Lisanti Capital Growth sold out of Privia Health (PRVA) in Q4 2022, closing a stake of 137,650 shares — an estimated $4.69M sold.

Lisanti Capital Growth first reported a position in PRVA in Q3 2022 and held it in 1 quarter. The position peaked at $4.69M in Q3 2022. 192 funds tracked by Wall St. Rank hold PRVA as of Q4 2022.

  • Lisanti Capital Growth reported no remaining Privia Health position as of Q4 2022 after selling out during the quarter.
  • Lisanti Capital Growth sold 137,650 Privia Health shares in Q4 2022, an estimated $4.69M.
  • Lisanti Capital Growth first reported a position in Privia Health in Q3 2022 and held it in 1 quarter.
  • Lisanti Capital Growth's Privia Health position peaked at $4.69M in Q3 2022.
  • 192 funds tracked by Wall St. Rank held Privia Health as of Q4 2022.

Based on Lisanti Capital Growth's 13F filing for Q4 2022, filed 6 Feb 2023.